Factitious hypermineralocorticoidism due to transdermal application of a 9-alpha-prednisolone containing ointment.
D000308:Adrenocortical Hyperfunction / Q000139:chemically induced*; D001446:Balanitis / Q000188:drug therapy; D005477:Fluprednisolone / Q000009:adverse effects* / Q000627:therapeutic use / Q000031:analogs & derivatives; D006801:Humans; D008297:Male; D008875:Middle Aged; D009824:Ointments
D009824:Ointments; C010958:9-fluoroprednisolone; D005477:Fluprednisolone